|
1
|
Jemal A, Siegel R, Ward E, Murray T, Xu J
and Thun MJ: Cancer statistics, 2007. CA Cancer J Clin. 57:43–66.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Metts MC, Metts JC, Milito SJ and Thomas
CR Jr: Bladder cancer: A review of diagnosis and management. J Natl
Med Assoc. 92:285–294. 2000.PubMed/NCBI
|
|
3
|
Cohen SM, Shirai T and Steineck G:
Epidemiology and etiology of premalignant and malignant urothelial
changes. Scand J Urol Nephrol Suppl. 205:105–115. 2000. View Article : Google Scholar
|
|
4
|
Vineis P, Talaska G, Malaveille C, Bartsch
H, Martone T, Sithisarankul P and Strickland P: DNA adducts in
urothelial cells: Relationship with biomarkers of exposure to
arylamines and polycyclic aromatic hydrocarbons from tobacco smoke.
Int J Cancer. 65:314–316. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Miyajima A, Nakashima J, Yoshioka K,
Tachibana M, Tazaki H and Murai M: Role of reactive oxygen species
in cis-dichlorodiammineplatinum-induced cytotoxicity on bladder
cancer cells. Br J Cancer. 76:206–210. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Levi F, La Vecchia C, Randimbison L and
Franceschi S: Incidence of infiltrating cancer following
superficial bladder carcinoma. Int J Cancer. 55:419–421. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Black PC and Dinney CP: Bladder cancer
angiogenesis and metastasis - translation from murine model to
clinical trial. Cancer Metastasis Rev. 26:623–634. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sherr CJ and Roberts JM: CDK inhibitors:
Positive and negative regulators of G1-phase progression. Genes
Dev. 13:1501–1512. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sherr CJ: Cancer cell cycles. Science.
274:1672–1677. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Matrisian LM: Metalloproteinases and their
inhibitors in matrix remodeling. Trends Genet. 6:121–125. 1990.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Liotta LA: Tumor invasion and metastases -
role of the extracellular matrix: Rhoads Memorial Award lecture.
Cancer Res. 46:1–7. 1986.PubMed/NCBI
|
|
12
|
Sier CF, Casetta G, Verheijen JH, Tizzani
A, Agape V, Kos J, Blasi F and Hanemaaijer R: Enhanced urinary
gelatinase activities (matrix metalloproteinases 2 and 9) are
associated with early-stage bladder carcinoma: A comparison with
clinically used tumor markers. Clin Cancer Res. 6:2333–2340.
2000.PubMed/NCBI
|
|
13
|
Gerhards S, Jung K, Koenig F, Daniltchenko
D, Hauptmann S, Schnorr D and Loening SA: Excretion of matrix
metalloproteinases 2 and 9 in urine is associated with a high stage
and grade of bladder carcinoma. Urology. 57:675–679. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kawamura K, Kamiya N, Suyama T, Shimbo M,
Oosumi N, Suzuki H, Ueda T, Tobe T, Igarashi T and Ito H: In situ
gelatinolytic activity correlates with tumor progression and
prognosis in patients with bladder cancer. J Urol. 172:1480–1484.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Qin H, Sun Y and Benveniste EN: The
transcription factors Sp1, Sp3, and AP-2 are required for
constitutive matrix metalloproteinase-2 gene expression in
astroglioma cells. J Biol Chem. 274:29130–29137. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bartel DP: MicroRNAs: Target recognition
and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhang B, Pan X, Cobb GP and Anderson TA:
microRNAs as oncogenes and tumor suppressors. Dev Biol. 302:1–12.
2007. View Article : Google Scholar
|
|
18
|
Koturbash I, Zemp FJ, Pogribny I and
Kovalchuk O: Small molecules with big effects: The role of the
microRNAome in cancer and carcinogenesis. Mutat Res. 722:94–105.
2011. View Article : Google Scholar
|
|
19
|
Zhou W, Shi G, Zhang Q, Wu Q, Li B and
Zhang Z: MicroRNA-20b promotes cell growth of breast cancer cells
partly via targeting phosphatase and tensin homologue (PTEN). Cell
Biosci. 4:622014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sun Y, Wu J, Wu SH, Thakur A, Bollig A,
Huang Y and Liao DJ: Expression profile of microRNAs in c-Myc
induced mouse mammary tumors. Breast Cancer Res Treat. 118:185–196.
2009. View Article : Google Scholar
|
|
21
|
Li D, Ilnytskyy Y, Kovalchuk A, Khachigian
LM, Bronson RT, Wang B and Kovalchuk O: Crucial role for early
growth response-1 in the transcriptional regulation of miR-20b in
breast cancer. Oncotarget. 4:1373–1387. 2013.PubMed/NCBI
|
|
22
|
Lei Z, Li B, Yang Z, Fang H, Zhang GM,
Feng ZH and Huang B: Regulation of HIF-1alpha and VEGF by miR-20b
tunes tumor cells to adapt to the alteration of oxygen
concentration. PLoS One. 4:e76292009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Cascio S, D'Andrea A, Ferla R, Surmacz E,
Gulotta E, Amodeo V, Bazan V, Gebbia N and Russo A: miR-20b
modulates VEGF expression by targeting HIF-1 alpha and STAT3 in
MCF-7 breast cancer cells. J Cell Physiol. 224:242–249.
2010.PubMed/NCBI
|
|
24
|
Zhu E, Wang X, Zheng B, Wang Q, Hao J,
Chen S, Zhao Q, Zhao L, Wu Z and Yin Z: miR-20b suppresses Th17
differentiation and the pathogenesis of experimental autoimmune
encephalomyelitis by targeting RORγt and STAT3. J Immunol.
192:5599–5609. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yun SJ, Jeong P, Kim WT, Kim TH, Lee YS,
Song PH, Choi YH, Kim IY, Moon SK and Kim WJ: Cell-free microRNAs
in urine as diagnostic and prognostic biomarkers of bladder cancer.
Int J Oncol. 41:1871–1878. 2012.PubMed/NCBI
|
|
26
|
Moon SK, Jung SY, Choi YH, Lee YC,
Patterson C and Kim CH: PDTC, metal chelating compound, induces G1
phase cell cycle arrest in vascular smooth muscle cells through
inducing p21Cip1 expression: Involvement of p38 mitogen
activated protein kinase. J Cell Physiol. 198:310–323. 2004.
View Article : Google Scholar
|
|
27
|
Lee SJ, Cho SC, Lee EJ, Kim S, Lee SB, Lim
JH, Choi YH, Kim WJ and Moon SK: Interleukin-20 promotes migration
of bladder cancer cells through extracellular signal-regulated
kinase (ERK)-mediated MMP-9 protein expression leading to nuclear
factor (NF-κB) activation by inducing the up-regulation of
p21WAF1 protein expression. J Biol Chem. 288:5539–5552.
2013. View Article : Google Scholar :
|
